NASDAQ:RNXT

RenovoRx Inc.


RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.

In The Press

RenovoRx Inc. News